Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

SSII vs DBVT vs ISRG vs ALKS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SSII
SS Innovations International, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$763M
5Y Perf.+1504.1%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-58.8%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+116.4%

SSII vs DBVT vs ISRG vs ALKS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SSII logoSSII
DBVT logoDBVT
ISRG logoISRG
ALKS logoALKS
IndustryMedical - DevicesBiotechnologyMedical - Instruments & SuppliesBiotechnology
Market Cap$763M$1712.35T$161.07B$5.90B
Revenue (TTM)$42M$0.00$10.58B$1.56B
Net Income (TTM)$-12M$-168M$2.98B$153M
Gross Margin46.0%66.3%65.4%
Operating Margin-19.2%30.5%12.3%
Forward P/E43.8x24.8x
Total Debt$3M$22M$303M$70M
Cash & Equiv.$3M$194M$3.37B$1.12B

SSII vs DBVT vs ISRG vs ALKSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SSII
DBVT
ISRG
ALKS
StockMay 20May 26Return
SS Innovations Inte… (SSII)1001604.1+1504.1%
DBV Technologies S.… (DBVT)10041.2-58.8%
Intuitive Surgical,… (ISRG)100234.6+134.6%
Alkermes plc (ALKS)100216.4+116.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: SSII vs DBVT vs ISRG vs ALKS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: SSII and ISRG are tied at the top with 2 categories each — the right choice depends on your priorities. Intuitive Surgical, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. DBVT and ALKS also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
SSII
SS Innovations International, Inc.
The Growth Play

SSII has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.

  • Rev growth 105.7%, EPS growth 40.0%, 3Y rev CAGR 207.7%
  • 162.0% 10Y total return vs ISRG's 5.5%
  • 105.7% revenue growth vs DBVT's -100.0%
  • Beta 0.01 vs DBVT's 1.26, lower leverage
Best for: growth exposure and long-term compounding
DBVT
DBV Technologies S.A.
The Income Pick

DBVT is the clearest fit if your priority is income & stability.

  • Dividend streak 0 yrs, beta 1.26
  • +110.4% vs SSII's -61.3%
Best for: income & stability
ISRG
Intuitive Surgical, Inc.
The Defensive Pick

ISRG is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
  • Beta 1.02, current ratio 4.87x
  • 28.2% margin vs SSII's -28.5%
  • 14.8% ROA vs DBVT's -89.0%
Best for: sleep-well-at-night and defensive
ALKS
Alkermes plc
The Value Play

ALKS is the clearest fit if your priority is value.

  • Lower P/E (24.8x vs 43.8x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthSSII logoSSII105.7% revenue growth vs DBVT's -100.0%
ValueALKS logoALKSLower P/E (24.8x vs 43.8x)
Quality / MarginsISRG logoISRG28.2% margin vs SSII's -28.5%
Stability / SafetySSII logoSSIIBeta 0.01 vs DBVT's 1.26, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs SSII's -61.3%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs DBVT's -89.0%

SSII vs DBVT vs ISRG vs ALKS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SSIISS Innovations International, Inc.
FY 2025
System Sales Member
100.0%$38M
DBVTDBV Technologies S.A.

Segment breakdown not available.

ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M

SSII vs DBVT vs ISRG vs ALKS — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

ISRG and DBVT operate at a comparable scale, with $10.6B and $0 in trailing revenue. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SSII's -28.5%. On growth, SSII holds the edge at +158.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSSII logoSSIISS Innovations In…DBVT logoDBVTDBV Technologies …ISRG logoISRGIntuitive Surgica…ALKS logoALKSAlkermes plc
RevenueTrailing 12 months$42M$0$10.6B$1.6B
EBITDAEarnings before interest/tax-$7M-$112M$3.8B$212M
Net IncomeAfter-tax profit-$12M-$168M$3.0B$153M
Free Cash FlowCash after capex-$22M-$151M$2.8B$392M
Gross MarginGross profit ÷ Revenue+46.0%+66.3%+65.4%
Operating MarginEBIT ÷ Revenue-19.2%+30.5%+12.3%
Net MarginNet income ÷ Revenue-28.5%+28.2%+9.8%
FCF MarginFCF ÷ Revenue-52.3%+26.8%+25.1%
Rev. Growth (YoY)Latest quarter vs prior year+158.4%+23.0%+28.2%
EPS Growth (YoY)Latest quarter vs prior year+69.0%+91.5%+18.8%-4.1%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ALKS leads this category, winning 3 of 5 comparable metrics.

At 24.8x trailing earnings, ALKS trades at a 57% valuation discount to ISRG's 57.6x P/E. On an enterprise value basis, ALKS's 17.3x EV/EBITDA is more attractive than ISRG's 43.6x.

MetricSSII logoSSIISS Innovations In…DBVT logoDBVTDBV Technologies …ISRG logoISRGIntuitive Surgica…ALKS logoALKSAlkermes plc
Market CapShares × price$763M$1712.35T$161.1B$5.9B
Enterprise ValueMkt cap + debt − cash$763M$1712.35T$158.0B$4.9B
Trailing P/EPrice ÷ TTM EPS-65.50x-0.76x57.62x24.76x
Forward P/EPrice ÷ next-FY EPS est.43.84x
PEG RatioP/E ÷ EPS growth rate2.65x
EV / EBITDAEnterprise value multiple43.62x17.25x
Price / SalesMarket cap ÷ Revenue17.96x16.00x4.00x
Price / BookPrice ÷ Book value/share20.43x0.66x9.17x3.28x
Price / FCFMarket cap ÷ FCF64.67x12.28x
ALKS leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 5 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-130 for DBVT. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs DBVT's 4/9, reflecting strong financial health.

MetricSSII logoSSIISS Innovations In…DBVT logoDBVTDBV Technologies …ISRG logoISRGIntuitive Surgica…ALKS logoALKSAlkermes plc
ROE (TTM)Return on equity-30.2%-130.2%+16.9%+8.8%
ROA (TTM)Return on assets-17.5%-89.0%+14.8%+5.4%
ROICReturn on invested capital-17.7%+15.0%+18.9%
ROCEReturn on capital employed-23.6%-145.7%+16.5%+14.2%
Piotroski ScoreFundamental quality 0–95467
Debt / EquityFinancial leverage0.08x0.13x0.02x0.04x
Net DebtTotal debt minus cash-$289,540-$172M-$3.1B-$1.0B
Cash & Equiv.Liquid assets$3M$194M$3.4B$1.1B
Total DebtShort + long-term debt$3M$22M$303M$70M
Interest CoverageEBIT ÷ Interest expense-7.35x-189.82x32.30x
ISRG leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

SSII leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in SSII five years ago would be worth $38,155 today (with dividends reinvested), compared to $3,090 for DBVT. Over the past 12 months, DBVT leads with a +110.4% total return vs SSII's -61.3%. The 3-year compound annual growth rate (CAGR) favors SSII at 82.1% vs ALKS's 4.6% — a key indicator of consistent wealth creation.

MetricSSII logoSSIISS Innovations In…DBVT logoDBVTDBV Technologies …ISRG logoISRGIntuitive Surgica…ALKS logoALKSAlkermes plc
YTD ReturnYear-to-date-30.4%+4.9%-19.3%+25.3%
1-Year ReturnPast 12 months-61.3%+110.4%-15.4%+16.5%
3-Year ReturnCumulative with dividends+503.7%+19.7%+49.6%+14.5%
5-Year ReturnCumulative with dividends+281.6%-69.1%+58.7%+60.9%
10-Year ReturnCumulative with dividends+162.0%-87.0%+554.2%-11.0%
CAGR (3Y)Annualised 3-year return+82.1%+6.2%+14.4%+4.6%
SSII leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SSII and ALKS each lead in 1 of 2 comparable metrics.

SSII is the less volatile stock with a 0.01 beta — it tends to amplify market swings less than DBVT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs SSII's 33.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSSII logoSSIISS Innovations In…DBVT logoDBVTDBV Technologies …ISRG logoISRGIntuitive Surgica…ALKS logoALKSAlkermes plc
Beta (5Y)Sensitivity to S&P 5000.01x1.26x1.02x1.06x
52-Week HighHighest price in past year$11.87$26.18$603.88$36.60
52-Week LowLowest price in past year$3.02$7.53$427.84$25.17
% of 52W HighCurrent price vs 52-week peak+33.1%+76.3%+75.1%+96.7%
RSI (14)Momentum oscillator 0–10039.148.142.460.2
Avg Volume (50D)Average daily shares traded54K252K1.8M2.3M
Evenly matched — SSII and ALKS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: DBVT as "Buy", ISRG as "Buy", ALKS as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44).

MetricSSII logoSSIISS Innovations In…DBVT logoDBVTDBV Technologies …ISRG logoISRGIntuitive Surgica…ALKS logoALKSAlkermes plc
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$46.33$622.60$44.00
# AnalystsCovering analysts155528
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+1.4%+0.5%
Insufficient data to determine a leader in this category.
Key Takeaway

ISRG leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ALKS leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 2 of 6 categories
Loading custom metrics...

SSII vs DBVT vs ISRG vs ALKS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SSII or DBVT or ISRG or ALKS a better buy right now?

For growth investors, SS Innovations International, Inc.

(SSII) is the stronger pick with 105. 7% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SSII or DBVT or ISRG or ALKS?

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

8x versus Intuitive Surgical, Inc. at 57. 6x.

03

Which is the better long-term investment — SSII or DBVT or ISRG or ALKS?

Over the past 5 years, SS Innovations International, Inc.

(SSII) delivered a total return of +281. 6%, compared to -69. 1% for DBV Technologies S. A. (DBVT). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus DBVT's -87. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SSII or DBVT or ISRG or ALKS?

By beta (market sensitivity over 5 years), SS Innovations International, Inc.

(SSII) is the lower-risk stock at 0. 01β versus DBV Technologies S. A. 's 1. 26β — meaning DBVT is approximately 8633% more volatile than SSII relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.

05

Which is growing faster — SSII or DBVT or ISRG or ALKS?

By revenue growth (latest reported year), SS Innovations International, Inc.

(SSII) is pulling ahead at 105. 7% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: SS Innovations International, Inc. grew EPS 40. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, SSII leads at 207. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SSII or DBVT or ISRG or ALKS?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -28. 5% for SS Innovations International, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -19. 2% for SSII. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SSII or DBVT or ISRG or ALKS more undervalued right now?

Analyst consensus price targets imply the most upside for DBVT: 131.

8% to $46. 33.

08

Which pays a better dividend — SSII or DBVT or ISRG or ALKS?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is SSII or DBVT or ISRG or ALKS better for a retirement portfolio?

For long-horizon retirement investors, SS Innovations International, Inc.

(SSII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), +162. 0% 10Y return). Both have compounded well over 10 years (SSII: +162. 0%, DBVT: -87. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SSII and DBVT and ISRG and ALKS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SSII is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ISRG is a mid-cap high-growth stock; ALKS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SSII

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 79%
  • Gross Margin > 27%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.